Rankings
▼
Calendar
JANX Q2 2020 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
JANX
Janux Therapeutics, Inc.
$835M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$1M
Net Income
-$2M
EPS (Diluted)
$-0.20
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$781,000
Free Cash Flow
-$781,000
Stock-Based Comp.
$2,000
← FY 2020
All Quarters
Q3 2020 →
